Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis BWenjun Wang(Chinese Academy of Sciences), Mingzhao Zhu(Chinese Academy of Sciences)Nature NanotechnologyMarch 2, 202010.1038/s41565-020-0648-yCited by 234SaveCiteExport RISWatch citationsRelated PapersMatrix stiffness regulates tumor cell intravasation through expression and ESRP1-mediated alternative splicing of MENA|Cell Reports|2023|28Diabetic hyperglycemia-induced glycation regulates tumor vasculature integrity via NF-κB-mediated GM-CSF secretion by tumor cells|Cell Biomaterials|2025|2